ISO 9001 Certified in Valuation Advisory

ISO 9001 Certified in Valuation Advisory

Valtech Insights

Valtech has a specialized team to perform regular market and valuation research to provide valuable insights to our exclusive clients

For private company ESOP valuation in Singapore, what are the accounting, valuation and taxation considerations? 

Categories: Valtech Insights|

In the dynamic landscape of business ownership and employee incentives, Employee Stock Ownership Plans (ESOPs) have gained prominence as a valuable mechanism to foster employee engagement and align company goals with individual objectives. In Singapore, a thriving hub for both local and international businesses, ESOPs are subject to specific regulations and guidelines that govern their valuation, accounting treatment, and taxation. This comprehensive guide delves into the essential aspects of ESOPs tailored for private companies operating within the Singaporean business environment, offering insights into how businesses can navigate the intricacies of ESOP implementation while ensuring compliance with the local regulatory framework.

The development of intangible asset valuation in Singapore 

Categories: Valtech Insights|

Intangible asset valuation in Singapore plays a pivotal role in the country's dynamic business environment. As a global financial hub and a center for innovation and technology, accurate valuation of intangible assets is essential for strategic decision-making, financing, and M&A activities. Singapore's strong regulatory framework, skilled workforce, and commitment to innovation make it a prime destination for businesses seeking to maximize the value of their intangible assets in the Asian market.

Biotech Valuation & Healthcare Valuation Service Updates

Categories: Business Valuation, Valtech Insights|Tags: , , , , |

Given the uncertainties associated with valuation of biotech enterprises, valuers can put stronger effort in benchmarking. A solid pool of comparable listed companies and comparable transaction will be highly useful to support valuation assumptions at different clinical trial phase.

Go to Top